PRE-CLINICAL DEVELOPMENT OF A GENE EDITING MEDICINAL PRODUCT FOR EPIDERMOLYSIS BULLOSA. New formal grant offer for the approval of the Clinical Protocol of the project Projects uri icon


  • R+D Contract

date/time interval

  • February 14, 2024 - August 14, 2025


  • enfermedades monogénicas de la piel; edición genómica; células madre epidérmicas; bioingeniería de tejidos